Tuesday saw the first session of the two webinars facilitated by the Department of Health and Social Care (DHSC) and the Tessa Jowell Brain Cancer Mission (TJBCM).
The events are aimed at increasing the number of successful funding applications in brain tumour research by providing an overview of current funding opportunities and how to create a successful proposal.
Our Chief Executive, Sue Farrington Smith MBE, presented to the virtual attendees stressing that, at Brain Tumour Research, our vision is to find a cure for all types of brain tumours and that, to accelerate this, our mission is to increase the UK investment in brain tumour research. It is through successful research funding applications that this investment will be increased.
Sue was also able to share that Brain Tumour Research is looking to invite applications for new Brain Tumour Research Centre of Excellence partnerships in the summer of 2022 and outlined the criteria that have made our existing partnerships with Queen Mary University of London (QMUL), Imperial College, London and the University of Plymouth so successful.
Other presenters were Dr Clemency Jolly, a Research Grants Manager at Cancer Research UK (CRUK), whose topic was ‘Funding opportunities and application strengths and weaknesses’. A similar topic was explored by Professor Ruth Plummer, Clinical Professor of Experimental Cancer Medicine, Newcastle University and a panel member of the National Institute for Health Research (NIHR).
The second session starts at 2.45pm today and is open to all researchers and clinicians who want to apply for brain tumour research funding. Register here: www.eventbrite.co.uk/e/funding-in-brain-tumour-research-successes-pitfalls-opportunities-tickets-170443675622
Sue said: “I found the NIHR and CRUK presentations enlightening, in particular how both organisations encouraged prospective applicants to talk to the grant managers and discuss their ideas before submitting. The importance of doing your homework before applying came through loud and clear.”
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.